Potential mechanism of Camellia luteoflora against colon adenocarcinoma: An integration of network pharmacology and molecular docking

doi:10.4251/wjgo.v17.i6.105782

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (174)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-7)

Tables (1-3)

Sum=133

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=30

Jun 15, 2025 (publication date) through Jun 16, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Jun 15, 2025; 17(6): 105782
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.105782

Full Size Figure Download Figure

Figure 5 The relationship of the hub genes with the stage of colon adenocarcinoma patients. Violin diagrams were used to represent the relationship of the hub genes with the stage of colon adenocarcinoma patients. Pr (> F) value < 0.05 was considered statistically significant which was red in the figure.

Citation: Dong YD, Wu XM, Liu WQ, Hu YW, Zhang H, Fang WD, Luo Q. Potential mechanism of Camellia luteoflora against colon adenocarcinoma: An integration of network pharmacology and molecular docking. World J Gastrointest Oncol 2025; 17(6): 105782
URL: https://www.wjgnet.com/1948-5204/full/v17/i6/105782.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i6.105782